期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Realgar(α-As_(4)S_(4))Treats Myelodysplastic Syndromes through Reducing DNA Hypermethylation 被引量:1
1
作者 ZHANG Miao ZHANG Jia-yi +2 位作者 SUN Ming-qian LU Peng LIU Jian-xun 《Chinese Journal of Integrative Medicine》 SCIE CAS CSCD 2022年第3期281-288,共8页
DNA hypermethylation is an epigenetic modification that plays a critical role in the oncogenesis of myelodysplastic syndromes(MDS).Aberrant DNA methylation represses the transcription of promotors of tumor suppressor ... DNA hypermethylation is an epigenetic modification that plays a critical role in the oncogenesis of myelodysplastic syndromes(MDS).Aberrant DNA methylation represses the transcription of promotors of tumor suppressor genes,inducing gene silencing.Realgar(α-As_(4)S_(4))is a traditional medicine used for the treatment of various diseases in the ancient time.Realgar was reported to have efficacy for acute promyelocytic leukemia(APL).It has been demonstrated that realgar could efficiently reduce DNA hypermethylation of MDS.This review discusses the mechanisms of realgar on inhibiting DNA hypermethylation of MDS,as well as the species and metabolisms of arsenic in vivo. 展开更多
关键词 myelodysplastic syndromes DNA hypermethylation REALGAR ARSENIC REVIEW
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部